← Eichor
Study identifier: NCT06674863 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Addressing Health Literacy With a Tailored Survivorship Care Plan

Condition: Localized Prostate Carcinoma · Oligometastatic Prostate Carcinoma · Stage IVB Prostate Cancer AJCC v8  ·  Sponsor: Emory University

PhaseNA
Planned participants150
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This clinical trial compares the impact of a tailored survivorship care plan (SCP) to a standard SCP on the understanding of and access to survivorship care in black or African American patients with prostate cancer that has not spread to other parts of the body (localized) or that has spread from where it first started (primary site) to a limited number of places in the body (oligometastatic). SCPs summarize treatment history and recommendations for monitoring and maintaining health, and may also include potential long term effects of treatments received. The intention of a SCP is to help patients participate in their own health care. However, many patients have below basic levels of health literacy, meaning, they have a lower ability to obtain, communicate, process and understand basic health information and services to make health decisions. In fact, poor health literacy has been linked with worse quality of life in prostate cancer survivors. A tailored SCP includes the addition of an educational supplement based on lower reading and writing skills (low literacy) and may address health literacy barriers to understanding of treatment options and side effects. A standard SCP uses a template based on the American Society of Clinical Oncology (ASCO) guidelines for prostate cancer. A tailored SCP with low literacy educational supplements may be more effective compared to a standard SCP in improving understanding and access to survivorship care in black or African American patie…

This description comes directly from the study's public registry record.

Talk to the study team

Kerry L. Kilbridge, MD, MSc  ·  617-632-2429  ·  Kerry_Kilbridge@DFCI.HARVARD.EDU

Always discuss trial participation with your own doctor first.

Locations (3)

Grady Memorial HospitalAtlanta, Georgia, United StatesRecruiting
Emory University Hospital/Winship Cancer InstituteAtlanta, Georgia, United StatesRecruiting
Atlanta VA Medical CenterAtlanta, Georgia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06674863